You are here

Article Text

Article menu
Download PDFPDF
Correspondence
SLE patients are not immune to covid-19: importance of sending the right message across
  1. Mohit Goyal
  1. Division of Rheumatology, CARE Pain & Arthritis Centre, Udaipur 313002, India
  1. Correspondence to Dr Mohit Goyal, Division of Rheumatology, CARE Pain & Arthritis Centre, Udaipur 313002, India; dr.mohitgoyal{at}gmail.com

https://doi.org/10.1136/annrheumdis-2020-217658

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In vitro inhibition of the novel coronavirus, SARS-CoV-2, by hydroxychloroquine (HCQ) has triggered further exploration of the clinical efficacy of this drug in covid-19. Rheumatologists all over the world are analysing registries of patients with systemic lupus erythematosus (SLE) and other rheumatic diseases to look at the prevalence of covid-19 in patients who have been on HCQ. On coming across the title, ‘SLE, hydroxychloroquine and no SLE patients with covid-19: a comment’, we read it with interest. The authors say, “There are several thousands of patients with covid-19 worldwide. Nevertheless, there is no case of SLE with covid-19”. There is no mention of any reference or source to the claim. They go on to extrapolate, “Hence, hydroxychloroquine …

    View Full Text

    Linked Articles